Bill Summary

HB 247 Telehealth Practice Standards (2021 Session)
Telehealth Practice Standards: Revises prohibition on prescribing controlled substances through use of telehealth to include only specified controlled substances. Effective Date: July 1, 2021
01/13/21
HOUSE 
Filed
01/22/21
HOUSE 
Referred to Professions & Public Health Subcommittee; Health Care Appropriations Subcommittee; Health & Human Services Committee
01/22/21
HOUSE 
Now in Professions & Public Health Subcommittee
03/19/21
HOUSE 
On Committee agenda - Professions & Public Health Subcommittee, 03/23/21, 12:45 pm, 306 H - PCS
03/23/21
HOUSE 
Favorable with CS by Professions & Public Health Subcommittee; 17 Yeas, 0 Nays
03/24/21
HOUSE 
Committee Substitute Text (C1) Filed
03/26/21
HOUSE 
Reference to Health Care Appropriations Subcommittee removed; Remaining reference: Health & Human Services Committee
03/26/21
HOUSE 
Now in Health & Human Services Committee
04/12/21
HOUSE 
On Committee agenda - Health & Human Services Committee, 04/14/21, 9:00 am, 17 H
04/14/21
HOUSE 
Favorable by Health & Human Services Committee; 20 Yeas, 0 Nays
04/14/21
HOUSE 
Placed on Calendar, on 2nd reading
04/18/21
HOUSE 
Placed on Special Order Calendar, 04/21/21
04/21/21
HOUSE 
Read Second Time; Placed on Third Reading, 04/22/21
04/22/21
HOUSE 
Read Third Time; Passed (Vote: 118 Yeas / 0 Nays)
04/22/21
SENATE
In Messages
04/22/21
SENATE
Received; Referred to Appropriations
04/30/21
SENATE
Died in Appropriations
0247
Filed on 01/13/21
PDF
Amendment 1000 PCS
Filed on 03/19/21
Adopted
0247C1
Filed on 03/24/21
PDF
No amendments to this bill text filed.
Research & Reports
Revenue Estimating Coverence Reports, Veto, Transmittal letters and more. Learn more.

No reports related to this bill.

Upcoming Events
Florida's most comprehensive legislative calendar. Learn more.

No events are scheduled at this time.

Press Releases
Related Press Announcements. Learn more.

No press releases related to this bill.

Features above are available to LobbyTools subscribers. Request a free demo or call (850) 915-0100 ext. 2 to learn more.